Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 3/20 | 0.53 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.47 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.47 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | CCR2 | P41597 | 13/20 | 0.46 |
| ▸ | MLYCD | O95822 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20088472 | 0.86 | TACR1 (0.49) | TACR1MTORCCR2MLYCD | |
| SCHEMBL20428059 | 0.84 | ERCC1 (0.57) | TACR1ERCC1ERCC4 | |
| SCHEMBL20088353 | 0.84 | SCN9A (0.54) | TACR1MTORCCR2 | |
| SCHEMBL20088440 | 0.84 | SCN9A (0.50) | TACR1MTORCCR2MLYCD | |
| SCHEMBL20088471 | 0.84 | SCN9A (0.54) | TACR1MTORCCR2 | |
| SCHEMBL18251695 | 0.80 | ERCC1 (0.50) | ERCC1ERCC4 | |
| SCHEMBL20088438 | 0.79 | TACR1 (0.49) | TACR1MTORMLYCD | |
| SCHEMBL25780517 | 0.79 | MTOR (0.46) | TACR1MTORCCR2MLYCD | |
| SCHEMBL13103578 | 0.79 | MLYCD (0.59) | TACR1ERCC1ERCC4MLYCD | |
| SCHEMBL18251700 | 0.78 | ERCC1 (0.55) | TACR1ERCC1ERCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190343802-A1 | CELL-PROTECTIVE COMPOUNDS AND THEIR USE | ETH Zürich (CH) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190343802-A1 | CELL-PROTECTIVE COMPOUNDS AND THEIR USE | SRPK2, SRSF2, SRPK1 | TACR1 4188/4885ERCC1 1690/4885ERCC4 967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.